Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 5.60
+0.45 (8.74%)
At close: Mar 27, 2026
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 10.1 billion as of March 27, 2026. Its market cap has increased by 75.29% in one year.
Market Cap
10.10B
Enterprise Value
10.19B
Revenue
1.04B
Ranking
n/a
PE Ratio
33.55
Stock Price
5.60
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 10.10B, a decrease of -14.67%. That is a compound annual growth rate of -3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 10.10B | 12.68% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 13.67B |
| Everest Medicines | 12.86B |
| HBM Holdings | 10.18B |
| CStone Pharmaceuticals | 10.14B |
| Guangzhou Innogen Pharmaceutical Group | 9.79B |
| Shanghai Haohai Biological Technology | 9.19B |
| CARsgen Therapeutics Holdings | 8.89B |
| Abbisko Cayman | 8.14B |